Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Avenir Wellness Solutions, Inc. (CURR)
|
Add to portfolio |
|
|
|
| Price: |
$0.39
| | Metrics |
| OS: |
72.4
|
M
| |
|
|
| Market cap: |
$28.3
|
M
| |
|
|
|
Net debt:
|
$410
|
k
| |
|
|
|
EV:
|
$28.7
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($8.3)
|
M
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Mar-31-16 | Dec-31-15 |
| Revenues | 6.6 | 2.1 | 0.6 | 0.6 | 0.2 | 0.1 | 0.0 | 0.2 |
| Revenue growth | 219.6% | 229.2% | 6.7% | 223.7% | 114.3% | -54.1% | 0.0% | |
| Cost of goods sold | 2.2 | 1.1 | 0.2 | 0.3 | 0.2 | 0.2 | 0.0 | 0.1 |
| Gross profit | 4.4 | 1.0 | 0.4 | 0.3 | 0.0 | -0.1 | 0.0 | 0.1 |
| Gross margin | 66.8% | 47.5% | 62.9% | 52.1% | -0.1% | -82.2% | 88.7% | 36.2% |
| Selling, general and administrative | 18.9 | 11.4 | 10.1 | 6.5 | 5.9 | 3.1 | | 0.9 |
| Research and development | 2.4 | 2.8 | 2.3 | 1.4 | 1.4 | 0.8 | | 0.7 |
| General and administrative | | | | | | | 0.0 | |
| EBITA | -13.5 | -12.5 | -13.6 | -7.5 | -7.3 | -3.9 | 0.0 | -1.5 |
| EBITA margin | -206.1% | -608.4% | -2184.8% | -1291.8% | -4069.8% | -4664.9% | -91.8% | -814.6% |
| Amortization of intangibles | 3.4 | 0.7 | | | | | | 0.0 |
| EBIT | -16.9 | -13.2 | -13.6 | -7.5 | -7.3 | -3.9 | 0.0 | -1.5 |
| EBIT margin | -257.9% | -642.6% | -2184.8% | -1291.8% | -4069.8% | -4664.9% | -91.8% | -837.1% |
| Pre-tax income | -13.2 | -30.6 | -21.4 | -10.4 | -8.2 | -4.2 | 0.0 | -1.6 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.3% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -13.2 | -30.6 | -21.4 | -10.4 | -8.1 | -4.2 | 0.0 | -1.6 |
| Net margin | -201.3% | -1493.0% | -3430.7% | -1781.0% | -4517.6% | -4939.7% | -91.8% | -873.9% |
| |
| Diluted EPS | ($0.26) | ($0.65) | ($0.62) | ($0.42) | ($0.34) | ($0.46) | | ($0.24) |
| Shares outstanding (diluted) | 50.2 | 47.3 | 34.5 | 25.0 | 23.6 | 9.1 | | 6.6 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|